Revolutionizing Skincare: Evonik Invests in Jland Biotech to Launch Vegan Collagen

Revolutionizing Skincare: Evonik Invests in Jland Biotech to Launch Vegan Collagen

(IN BRIEF) Evonik has partnered with Jland Biotech to introduce vegan collagen for cosmetic and personal care applications. Through an investment from Evonik’s Venture Capital group, the collaboration aims to meet the rising demand for sustainable collagen solutions in skincare. This partnership will enable Evonik to offer commercial quantities of collagen for products like anti-aging and hydrating creams, leveraging Jland’s innovative approach to non-animal-derived collagen production. Together, they plan to revolutionize the cosmetics industry by delivering cutting-edge beauty solutions to global consumers.

(PRESS RELEASE) ESSEN, 22-Feb-2024 — /EuropaWire/ —  Evonik (ETR: EVK), one of the world leaders in specialty chemicals, has joined forces with Jland Biotech, a Chinese biotech company, to introduce vegan collagen for cosmetic and personal care applications. Through an investment from Evonik’s Venture Capital group, the partnership aims to address the increasing market demand for sustainable collagen solutions in skincare. This collaboration will enable Evonik to offer commercial quantities of collagen for products like anti-aging and hydrating creams. Leveraging Jland’s innovative approach to non-animal-derived collagen production, Evonik plans to expand its collagen platform and enhance its existing portfolio of vegan collagen products. With a shared commitment to scientific advancement and sustainability, both companies are poised to revolutionize the cosmetics industry by delivering cutting-edge beauty solutions to global consumers.

“Evonik’s life sciences division is using its biotechnology platform to leverage the expertise of its partners and collaborate on precision biosolutions. We welcome Jland to our partner network,” said Johann-Caspar Gammelin, President of Evonik’s Nutrition & Care division. “Together with our expertise in active ingredients and delivery systems, we are creating a world-leading portfolio of non-animal derived collagen.”

Yann d’Hervé, Head of Evonik’s Care Solutions business line, added, “We value Jland’s outstanding approach to innovation and look forward to helping our customers develop the science-based, sophisticated beauty solutions that consumers worldwide are looking for.”

Collagen is a protein found in human and animal structural tissues such as bones, cartilage, skin and nails. Currently, most collagen is derived from animal tissue, but non-animal collagen is increasingly in demand. Produced from bacteria or yeast through a controlled fermentation-based process, non-animal collagen is easier to formulate and better absorbed by the skin than animal-derived collagen. Fermentation-based collagen also has low immunogenicity and batch-to-batch variability and is highly reproducible.

Jland Biotech is a company dedicated to developing and manufacturing non-animal-derived collagen. It was founded in 2015 and has its headquarters in Jingjiang, China. Jland’s core technology is centred around a production process that seamlessly incorporates efficiency and scalability.

Jland Biotech, renowned for its innovative collagen production process, offers a range of vegan collagen products that are fully registered with the Vegan Society. By harnessing fermentation-based technology, non-animal collagen offers superior absorption, formulation flexibility, and reproducibility compared to traditional animal-derived collagen.

Evonik’s expertise in skin care, coupled with Jland’s cutting-edge technology, positions the partnership as a leader in delivering innovative and sustainable collagen solutions to meet the evolving needs of the cosmetics industry.